FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

38731911000001106: Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1556341000001110 Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1556351000001113 Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has AMP Rybelsus 3mg tablets (Novo Nordisk Ltd) true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Is a Semaglutide 3mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Semaglutide true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rybelsus 3mg tablets (Novo Nordisk Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start